The Dextrose Injection, cataloged under National Stock Number 6505-01-247-9167, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Astra Pharmaceuticals Lp. Government technical data includes 9 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. 1 item shares a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-247-9167 |
| Primary Part Number | NDC00186-1170-04 |
| Item Name | Dextrose Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Astra Pharmaceuticals Lp |
| Status | ACTIVE |
| Administration | INTRAVENOUS |
| Primary Container Content Quantity | 50.000 MILLILITERS |
| Secondary Container Type | PACKAGE |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | VIAL |
| Total Secondary Container Quantity | 2 |
| Primary Container Quantity Per Secondary Container | 25 VIAL |
| Active Medicament Medicinal Strength | 50.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT |
| Total Primary Container Quantity | 100 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Hazardous per DLA record (HMIC Y) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC00186-1170-04 PRIMARY | Astra Pharmaceuticals Lp (USA) |
| Reference | Meaning |
|---|---|
| NDC00469-3770-25 | 5/9 Secondary reference Lyphomed Inc Div of Fujisawa Usa Inc |
| 36750 | 5/9 Secondary reference Lyphomed Inc Div of Fujisawa Usa Inc |
NSN 6505-01-247-9167 is a Dextrose Injection, manufactured by Astra Pharmaceuticals Lp, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-247-9167 has 1 manufacturer part number on file: NDC00186-1170-04 (Astra Pharmaceuticals Lp).
1 possible match (shared part number, not a government interchangeability claim): 5310-01-559-9307. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00186-1170-04: Administration: INTRAVENOUS; Primary Container Content Quantity: 50.000 MILLILITERS; Secondary Container Type: PACKAGE; Medical Designation and Grade: UNITED STATES PHARMACOPEIA. 9 specifications are documented in the U.S. Government catalog.
Hazardous per DLA record (HMIC Y). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.